Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection

NCT04626856 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Rotavirus Infection

Interventions

BIOLOGICAL: Low dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Medium dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: High dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Low dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Medium dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: High dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Low dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Medium dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: High dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Low dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Medium dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: High dosage IRV on a 0- and 28-day schedule
BIOLOGICAL: Low dosage IRV on a 0- , 28- and 56-day schedule
BIOLOGICAL: Medium dosage IRV on a 0- , 28- and 56-day schedule
BIOLOGICAL: High dosage IRV on a 0- , 28- and 56-day schedule
BIOLOGICAL: Placebo on day 0, 28
BIOLOGICAL: Placebo on day 0, 28, 56

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]